Source: Health Canada shortage reports · Updated Sep 4, 2026
Some Fluoxetine products are in shortage in Canada (3 of 36 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 23, 2026.
An antidepressant (SSRI) used to treat depression, anxiety and obsessive-compulsive disorder.
Products affected
3 / 36
In shortage since
Aug 1, 2024
Est. full return
Oct 23, 2026
Reports on file
113
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-FLUOXETINE
20MG · SOLUTION · APOTEX INC
DIN 02231328 · since Aug 18, 2026, est. end Oct 23, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACH-FLUOXETINE
20MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02383241 · since Aug 20, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ACH-FLUOXETINE
10MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02393441 · since Sep 15, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ACH-FLUOXETINE
20MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02383241 · since Aug 1, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Resolved
JAMP-FLUOXETINE
20MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02386402 · ended Jul 2, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP-FLUOXETINE
10MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02401894 · ended Jul 2, 2026 · Disruption of the manufacture of the drug.
Resolved
FLUOXETINE
20MG · CAPSULE · SANIS HEALTH INC
DIN 02286076 · ended Apr 28, 2026 · Disruption of the manufacture of the drug.
Resolved
FLUOXETINE
20MG · CAPSULE · SANIS HEALTH INC
DIN 02286076 · ended Apr 28, 2026 · Disruption of the manufacture of the drug.
Resolved
FLUOXETINE
10MG · CAPSULE · SANIS HEALTH INC
DIN 02286068 · ended Apr 28, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-FLUOXETINE
10MG · CAPSULE · APOTEX INC
DIN 02216353 · ended Mar 12, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUOXETINE
20MG · CAPSULE · TEVA CANADA LIMITED
DIN 02216590 · ended Jan 21, 2026 · Disruption of the manufacture of the drug.
Resolved
PMS-FLUOXETINE
60MG · CAPSULE · PHARMASCIENCE INC
DIN 02464659 · ended Dec 15, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Fluoxetine is currently affected by 3 active shortage reports filed with Health Canada by APOTEX INC, ACCORD HEALTHCARE INC.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Fluoxetine is classified under “ANTIDEPRESSANTS” (ATC N06AB).
Recent changes
Sep 4, 2026
Estimated end date pushed back : Oct 2, 2026 → Oct 23, 2026
Aug 21, 2026
New report filed
Common questions
What is Fluoxetine used for?
An antidepressant (SSRI) used to treat depression, anxiety and obsessive-compulsive disorder.
When will Fluoxetine be back in stock in Canada?
The latest manufacturer estimate is Oct 23, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Fluoxetine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.